First Time Loading...

Bio Rad Laboratories Inc
NYSE:BIO

Watchlist Manager
Bio Rad Laboratories Inc Logo
Bio Rad Laboratories Inc
NYSE:BIO
Watchlist
Price: 279.83 USD 0.19% Market Closed
Updated: May 6, 2024

Bio Rad Laboratories Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bio Rad Laboratories Inc
Revenue Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Bio Rad Laboratories Inc
NYSE:BIO
Revenue
$2.7B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
2%
Thermo Fisher Scientific Inc
NYSE:TMO
Revenue
$42.9B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
13%
Danaher Corp
NYSE:DHR
Revenue
$43.7B
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
9%
Mettler-Toledo International Inc
NYSE:MTD
Revenue
$3.8B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
5%
Agilent Technologies Inc
NYSE:A
Revenue
$6.7B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
8%
IQVIA Holdings Inc
NYSE:IQV
Revenue
$15B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
11%

Bio Rad Laboratories Inc
Revenue Breakdown

Breakdown by Geography
Bio Rad Laboratories Inc

Total Revenue: 2.7B USD
100%
United States: 1.1B USD
42%
Europe: 819.8m USD
30.7%
Asia: 563m USD
21.1%
Other (Primarily Canada And Latin America): 166.6m USD
6.2%
Show More
Show Less

Breakdown by Segments
Bio Rad Laboratories Inc

Total Revenue: 2.7B USD
100%
Clinical Diagnostics: 1.5B USD
55.8%
Life Science: 1.2B USD
44.1%
All Other Segments: 3.6m USD
0.1%

See Also

What is Bio Rad Laboratories Inc's Revenue?
Revenue
2.7B USD

Based on the financial report for Dec 31, 2023, Bio Rad Laboratories Inc's Revenue amounts to 2.7B USD.

What is Bio Rad Laboratories Inc's Revenue growth rate?
Revenue CAGR 10Y
2%

Over the last year, the Revenue growth was -5%. The average annual Revenue growth rates for Bio Rad Laboratories Inc have been 2% over the past three years , 3% over the past five years , and 2% over the past ten years .